List of works - Oscar Lorenzo

ACE inhibitors and AT(1) receptor antagonists-beyond the haemodynamic effect

scientific article published on 01 May 2000

Activation of the endosome-associated ubiquitin isopeptidase AMSH by STAM, a component of the multivesicular body-sorting machinery

scientific article

Activation of toll-like receptors and inflammasome complexes in the diabetic cardiomyopathy-associated inflammation.

scientific article published on 12 March 2014

Addition of Probiotics to Anti-Obesity Therapy by Percutaneous Electrical Stimulation of Dermatome T6. A Pilot Study

scientific article published on 03 October 2020

Alteration of energy substrates and ROS production in diabetic cardiomyopathy

scientific article

Analysis of phosphoinositide binding domain properties within the myotubularin-related protein MTMR3.

scientific article

Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms

scientific article published on 01 June 2000

Angiotensin II increases connective tissue growth factor in the kidney.

scientific article published in November 2003

Angiotensin II increases parathyroid hormone-related protein (PTHrP) and the type 1 PTH/PTHrP receptor in the kidney

scientific article published on 01 June 2002

Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.

scientific article published in December 2002

Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction.

scientific article

Angiotensin III activates nuclear transcription factor-kappaB in cultured mesangial cells mainly via AT(2) receptors: studies with AT(1) receptor-knockout mice

scientific article published on 01 May 2002

Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells

scientific article published on 01 June 2000

Angiotensin IV Activates the Nuclear Transcription Factor-κB and Related Proinflammatory Genes in Vascular Smooth Muscle Cells

article

Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System

scientific article published on 04 September 2020

Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.

scientific article published on May 2009

Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease.

scientific article published on 25 April 2016

Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease

scientific article

Comparison of 3 Predictive Clinical Risk Scores in 603 Patients with Stable Coronary Artery Disease

scientific article published on August 2017

Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis

scientific article published on 2 September 2003

Customized Dietary Intervention Avoids Unintentional Weight Loss and Modulates Circulating miRNAs Footprint in Huntington's Disease

scientific article published on 08 November 2018

Diagnostic approaches for diabetic cardiomyopathy.

scientific article

Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.

scientific article published on 19 December 2014

Differential redox regulation within the PTP superfamily

scientific article

Endogenous NAMPT dampens chemokine expression and apoptotic responses in stressed tubular cells

scientific article published on 25 November 2013

Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes

scientific article

IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus

scientific article published on 13 June 2017

Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate.

scientific article published on 23 August 2015

Inflammation and angiotensin II.

scientific article

Linking LOXL2 to Cardiac Interstitial Fibrosis

scientific article published on 18 August 2020

Lipid Biomarkers as Predictors of Diastolic Dysfunction in Diabetes with Poor Glycemic Control

scientific article published on 18 July 2020

N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease

scientific article published on 5 June 2015

Parathormone Levels Are Independently Associated with the Presence of Left Ventricular Hypertrophy in Patients with Coronary Artery Disease.

scientific article published in January 2016

Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases

scientific article

Potential role of nuclear factor κB in diabetic cardiomyopathy.

scientific article

Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases

scientific article published on 30 October 2019

Proinflammatory actions of angiotensins.

scientific article

Proteome changes in the myocardium of experimental chronic diabetes and hypertension

scientific article published on 30 December 2011

Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential.

scientific article published on 26 July 2016

Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes.

scientific article published on 04 April 2017

Role of the renin-angiotensin system in vascular diseases: expanding the field.

scientific article

Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway.

scientific article

Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking

scientific article published on 11 January 2018

Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms

scientific article (publication date: 2013)

Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease.

scientific article published on 15 June 2017

Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome related functions

scientific article published on 20 June 2006

Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors

scientific article

Targeting inflammation in diabetic nephropathy: a tale of hope

scientific article published on 23 October 2018

Targeting metabolic disturbance in the diabetic heart

scientific article

The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables.

scientific article published on 14 May 2015

The myotubularin family of lipid phosphatases

scientific article

The proteomic approach in the development of prognostic biomarkers in atherothrombosis

scientific article published on 01 January 2009

Updating experimental models of diabetic cardiomyopathy

scientific article published on 20 April 2015

Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease.

scientific article

Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease

scientific article published on 7 November 2013

[Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease]

scientific article published on 13 August 2014

List of works by Oscar Lorenzo

ACE inhibitors and AT(1) receptor antagonists-beyond the haemodynamic effect

Activation of the endosome-associated ubiquitin isopeptidase AMSH by STAM, a component of the multivesicular body-sorting machinery

Activation of toll-like receptors and inflammasome complexes in the diabetic cardiomyopathy-associated inflammation.

Addition of Probiotics to Anti-Obesity Therapy by Percutaneous Electrical Stimulation of Dermatome T6. A Pilot Study

Alteration of energy substrates and ROS production in diabetic cardiomyopathy

Analysis of phosphoinositide binding domain properties within the myotubularin-related protein MTMR3.

Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms

Angiotensin II increases connective tissue growth factor in the kidney.

Angiotensin II increases parathyroid hormone-related protein (PTHrP) and the type 1 PTH/PTHrP receptor in the kidney

Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.

Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction.

Angiotensin III activates nuclear transcription factor-kappaB in cultured mesangial cells mainly via AT(2) receptors: studies with AT(1) receptor-knockout mice

Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells

Angiotensin IV Activates the Nuclear Transcription Factor-κB and Related Proinflammatory Genes in Vascular Smooth Muscle Cells

Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System

Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.

Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease.

Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease

Comparison of 3 Predictive Clinical Risk Scores in 603 Patients with Stable Coronary Artery Disease

Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis

Customized Dietary Intervention Avoids Unintentional Weight Loss and Modulates Circulating miRNAs Footprint in Huntington's Disease

Diagnostic approaches for diabetic cardiomyopathy.

Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.

Differential redox regulation within the PTP superfamily

Endogenous NAMPT dampens chemokine expression and apoptotic responses in stressed tubular cells

Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes

IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus

Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate.

Inflammation and angiotensin II.

Linking LOXL2 to Cardiac Interstitial Fibrosis

Lipid Biomarkers as Predictors of Diastolic Dysfunction in Diabetes with Poor Glycemic Control

N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease

Parathormone Levels Are Independently Associated with the Presence of Left Ventricular Hypertrophy in Patients with Coronary Artery Disease.

Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases

Potential role of nuclear factor κB in diabetic cardiomyopathy.

Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases

Proinflammatory actions of angiotensins.

Proteome changes in the myocardium of experimental chronic diabetes and hypertension

Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential.

Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes.

Role of the renin-angiotensin system in vascular diseases: expanding the field.

Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway.

Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking

Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms

Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease.

Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome related functions

Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors

Targeting inflammation in diabetic nephropathy: a tale of hope

Targeting metabolic disturbance in the diabetic heart

The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables.

The myotubularin family of lipid phosphatases

The proteomic approach in the development of prognostic biomarkers in atherothrombosis

Updating experimental models of diabetic cardiomyopathy

Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease.

Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease

[Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease]